SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales AgreementAt the Market Issuance Sales Agreement • May 3rd, 2012 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledMay 3rd, 2012 Company Industry JurisdictionSynta Pharmaceuticals Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows: